Pascal Soriot

Pascal Soriot

business executive United Kingdom

Pascal Soriot is the chief executive of AstraZeneca, known for his leadership during the COVID-19 pandemic and his role in the recent cancellation of a significant investment in vaccine production in the UK, citing unmet financial support requirements.

Global Media Ratings
Dominance
0.02%
Persistence
0 wks
Reach
1,450,639
Power
16,061$
Sentiment
7.82
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
China 2 8.00 0.10% +0% 1,402,112,000 1,394,443 $14,000,000 13,923$
Taiwan 1 7.00 0.10% +0% 23,816,775 24,402 $670,000 686$
Australia 1 6.00 0.05% +0% 25,499,884 12,984 $1,380,000 703$
United Kingdom 1 5.00 0.03% +0% 67,886,011 18,810 $2,700,000 748$
Totals 5 1,519,314,670 1,450,639 $18,750,000 16,060$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

China China: Pascal Soriot, the CEO of AstraZeneca, expressed commitment to investing in a world-class innovation ecosystem in China. 8

People's Daily: “硬数据”与“软环境”(望海楼) --观点--人民网

Australia Australia: AstraZeneca chief executive Pascal Soriot announced plans for the pharmaceuticals giant to invest $US2.5 billion into a new research and development facility in the Chinese capital. 6

The Sydney Morning Herald: The Trump turmoil has handed China a golden opportunity

United Kingdom United Kingdom: Pascal Soriot, the chief executive of AstraZeneca, stated that the $2.5bn investment reflects their belief in the life sciences ecosystem in Beijing. 9

The Guardian: AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing | AstraZeneca